Developer docs
API playgroundTry for free, no card

Search company profiles

Neo-Bionica

Full company profile

uuid0003czw

Namestring
Neo-Bionica
Legal namestring
Neo-Bionica
Websiteurl
neo-bionica.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFitzroy, Australia
HQ citystring
Fitzroy
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurotechnology CDMO, implantable medical devices, contract development manufacturing, active implantable devices, clinical-grade prototyping
Industry2 codes
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code4 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
  • Pharmaceutical and Medicine Manufacturing3254
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Medical Device Contract Manufacturing
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1CDMO Design & Engineering Services
TypeProfessional Services
Description

Fee-for-service revenue from end-to-end design, engineering, and clinical-grade manufacturing engagements spanning conceptual feasibility through First-in-Human devices and scalable production. Engagement models are flexible and fit-for-purpose with no volume requirements or long-term commitments.

neo-bionica.com
2Pre-Clinical and Clinical Trial Build Services
TypeProfessional Services
Description

Traceable small-batch production in controlled environments for preclinical and clinical trial builds, pilot production, and clinical-grade pilot manufacturing runs.

neo-bionica.com
3Regulatory and Commercialisation Support Services
TypeProfessional Services
Description

Regulatory support for TGA, FDA, and MDR pathways, technical documentation, risk assessment, DHF/DMR development, clinical trial and ethics support, and IP/technology transfer to manufacturing partners.

neo-bionica.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Quote-based, project-scoped engagements; no fixed price tiers disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Flexible fit-for-purpose scopes without volume requirements or long-term commitments. Pricing determined per project through 'Discuss Your Device' consultation.

neo-bionica.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Neo-Bionica is a contract development and manufacturing organization (CDMO) that provides end-to-end design, engineering, prototyping, and clinical-grade manufacturing services for active implantable and wearable neurotechnology medical devices, taking clients from early-stage concept through First-in-Human clinical trials. Its service platform is organized into five interlocking modules: Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture, all delivered from an ISO 13485-certified, hospital-integrated facility at St. Vincent's Hospital Melbourne.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Secured $1 million in funding for client Kali Healthcare through prototype development support
+2 more records
Product overview1 text field

Neo-Bionica offers a single unified CDMO service platform (marketed as "the world's only CDMO focused exclusively on implantable and wearable electronics and electrodes for neuromonitoring and neuromodulation devices") organized into five interlocking service modules — Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture — which together operationalize their three-phase Pathway Definition → Iterative Development and Risk Mitigation → First-in-Human Manufacturing methodology, with the published Neurotech Implantables White Paper serving as a thought-leadership asset supporting client acquisition.

Product and service6 records
1Implantable Neurotechnology CDMO Services (unified platform)
CategoryCDMO Services / Contract Development and Manufacturing
Description

End-to-end contract development and manufacturing services for active implantable and wearable neurotechnology medical devices, organised into five interlocking service modules (Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture) that take clients from early-stage concept through First-in-Human clinical trials and scalable production. Specifically structured for early-phase innovation and small production runs with no volume requirements or long-term commitments.

2Design and Develop
CategoryCDMO Services - Design and Engineering
Description

End-to-end engineering design services from early concept through design transfer, covering electronic circuit design and miniaturisation, mechanical design for implants and wearables, embedded firmware and software development, systems engineering and integration, automated testing systems, and functional, performance, and lifetime testing.

3Build and Assemble
CategoryCDMO Services - Cleanroom Manufacturing and Assembly
Description

Precision fabrication and ISO 7 cleanroom assembly for neurotech devices, including microelectronics and SMT assembly, wire bonding (ball and wedge), laser welding and laser marking, UV/epoxy/Parylene encapsulation, potting, sealing, micro soldering, and custom fixtures, tooling, and integration of medical-grade materials.

4Test and Validate
CategoryCDMO Services - Verification and Validation
Description

In-house verification testing covering optical, electrical, and wireless (RF) performance; thermal cycling, humidity, and mechanical fatigue; biocompatibility and environmental resilience; test method development, design verification, and traceability; and hermetization and hermeticity testing using a Pfeiffer PRISMAPro mass spectrometer.

5Commercialise
CategoryCDMO Services - Regulatory and Commercialisation
Description

Regulatory and market-readiness services including an ISO 13485:2016 certified quality management system, regulatory support for TGA, FDA, and MDR pathways, technical documentation, risk assessment, DHF and DMR compilation, clinical trial and ethics support, IP alignment, and technology transfer to manufacturing partners.

6Prototype and Manufacture
CategoryCDMO Services - Prototyping and Pilot Production
Description

Manufacturing services spanning rapid prototyping and fast-paced iteration, pre-clinical and clinical trial builds, pilot production, and traceable small-batch production in controlled environments, from first concept through First-in-Human device builds.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Neo-Bionica's operational headquarters is housed within St. Vincent's Hospital Melbourne, providing immediate access to clinical practitioners and surgical professionals who represent the device's ultimate end-users. This hospital-integrated model enables direct clinical collaboration and is positioned as a key speed-to-First-in-Human advantage. Facilities including ISO 7 cleanrooms, hermeticity testing, laser seam welding, and microfabrication are co-located inside the hospital.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Robert Crombie, Head of Enterprise Partnerships & Innovation Initiatives at the University of Melbourne, represents the University on the Neo-Bionica Board, bringing extensive experience in biotech strategy and business development. The partnership provides access to academic research, talent, and innovation pipelines from one of Australia's leading biomedical research institutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based CDMO specializing in active implantable medical devices, neuromodulation, and minimally invasive surgical devices. Closest direct peer to Neo-Bionica in terms of active implantable electronics manufacturing and Class III device engineering depth.

TypeDirect peer
Description

Medical device CDMO with strong active implantable and neuro/neuromodulation capabilities, providing design, manufacturing, and regulatory services. Direct peer in the neurotech-focused contract development and manufacturing niche.

TypeDirect peer
Description

Canadian medical device design, development, and contract manufacturing organization serving startups through commercial-stage medtech. Direct peer in early-stage medical device CDMO services, including neurotech and Class III programs.

TypeRegional player
Description

Australian medical device and life sciences product development and manufacturing company, including Class III implantable work. Direct regional peer with overlapping capabilities in neurotech-adjacent implantable engineering.

TypeBroad incumbent
Description

Large US-listed medical device outsource manufacturer with significant active implantable and neuromodulation manufacturing capacity. Broad incumbent competing in the same end-markets from a much larger scale.

TypeBroad incumbent
Description

Global medical device contract manufacturer with capabilities in nitinol, laser processing, and complex implantable components. Broad incumbent serving overlapping neurotech and implantable customer bases.

7Nordson Medical
TypeBroad incumbent
Description

Medical device component and contract manufacturing business of Nordson, including precision engineered components for neuro and other implantables. Broad incumbent with overlapping manufacturing capabilities.

TypeEmerging player
Description

Deep-tech product development and engineering consultancy with active neurotechnology and brain-computer interface practices. Emerging player providing adjacent design and development services to the same neurotech startup segment.

TypeEmerging player
Description

UK-based technology and product development consultancy with deep neurotech, drug delivery, and implantable device capabilities. Emerging player offering competing design and engineering services to neurotech innovators.

TypeEmerging player
Description

Swiss engineering services and product development firm with a dedicated medical devices and neurotechnology practice. Emerging player providing comparable design and development services to early-stage neurotech clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neo-Bionica

Medical Device Contract Manufacturingneo-bionica.com

Neo-Bionica firmographics

Firmographics
Name
Neo-Bionica
Legal name
Neo-Bionica
Website
https://neo-bionica.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Neo-Bionica industry classification

Industry
Product category
Medical Device Contract Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Neurotechnology CDMO
  • Implantable medical devices
  • Contract development manufacturing
  • Active implantable devices
  • Clinical-grade prototyping

Where Neo-Bionica is headquartered

Location

Headquarters

HQ city
Fitzroy
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Neo-Bionica business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. CDMO Design & Engineering Services: Fee-for-service revenue from end-to-end design, engineering, and clinical-grade manufacturing engagements spanning conceptual feasibility through First-in-Human devices and scalable production. Engagement models are flexible and fit-for-purpose with no volume requirements or long-term commitments.
  2. Pre-Clinical and Clinical Trial Build Services: Traceable small-batch production in controlled environments for preclinical and clinical trial builds, pilot production, and clinical-grade pilot manufacturing runs.
  3. Regulatory and Commercialisation Support Services: Regulatory support for TGA, FDA, and MDR pathways, technical documentation, risk assessment, DHF/DMR development, clinical trial and ethics support, and IP/technology transfer to manufacturing partners.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based, project-scoped engagements; no fixed price tiers disclosed

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Neo-Bionica product offering

Product offering

Core offering

Neo-Bionica is a contract development and manufacturing organization (CDMO) that provides end-to-end design, engineering, prototyping, and clinical-grade manufacturing services for active implantable and wearable neurotechnology medical devices, taking clients from early-stage concept through First-in-Human clinical trials. Its service platform is organized into five interlocking modules: Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture, all delivered from an ISO 13485-certified, hospital-integrated facility at St. Vincent's Hospital Melbourne.

Product overview

Neo-Bionica offers a single unified CDMO service platform (marketed as "the world's only CDMO focused exclusively on implantable and wearable electronics and electrodes for neuromonitoring and neuromodulation devices") organized into five interlocking service modules — Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture — which together operationalize their three-phase Pathway Definition → Iterative Development and Risk Mitigation → First-in-Human Manufacturing methodology, with the published Neurotech Implantables White Paper serving as a thought-leadership asset supporting client acquisition.

Differentiator

Problem solved

Functional benefit

Products and services

  • Implantable Neurotechnology CDMO Services (unified platform) End-to-end contract development and manufacturing services for active implantable and wearable neurotechnology medical devices, organised into five interlocking service modules (Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture) that take clients from early-stage concept through First-in-Human clinical trials and scalable production. Specifically structured for early-phase innovation and small production runs with no volume requirements or long-term commitments.
  • Design and Develop End-to-end engineering design services from early concept through design transfer, covering electronic circuit design and miniaturisation, mechanical design for implants and wearables, embedded firmware and software development, systems engineering and integration, automated testing systems, and functional, performance, and lifetime testing.
  • Build and Assemble Precision fabrication and ISO 7 cleanroom assembly for neurotech devices, including microelectronics and SMT assembly, wire bonding (ball and wedge), laser welding and laser marking, UV/epoxy/Parylene encapsulation, potting, sealing, micro soldering, and custom fixtures, tooling, and integration of medical-grade materials.
  • Test and Validate In-house verification testing covering optical, electrical, and wireless (RF) performance; thermal cycling, humidity, and mechanical fatigue; biocompatibility and environmental resilience; test method development, design verification, and traceability; and hermetization and hermeticity testing using a Pfeiffer PRISMAPro mass spectrometer.
  • Commercialise Regulatory and market-readiness services including an ISO 13485:2016 certified quality management system, regulatory support for TGA, FDA, and MDR pathways, technical documentation, risk assessment, DHF and DMR compilation, clinical trial and ethics support, IP alignment, and technology transfer to manufacturing partners.
  • Prototype and Manufacture Manufacturing services spanning rapid prototyping and fast-paced iteration, pre-clinical and clinical trial builds, pilot production, and traceable small-batch production in controlled environments, from first concept through First-in-Human device builds.

Quantifiable outcome

  • Secured $1 million in funding for client Kali Healthcare through prototype development support
  • +2 more outcomes

Companies that use Neo-Bionica

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Neo-Bionica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature8 records

Neo-Bionica partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • St. Vincent's Hospital MelbourneflagshipStrategic or Co-development PartnerNeo-Bionica's operational headquarters is housed within St. Vincent's Hospital Melbourne, providing immediate access to clinical practitioners and surgical professionals who represent the device's ultimate end-users. This hospital-integrated model enables direct clinical collaboration and is positioned as a key speed-to-First-in-Human advantage. Facilities including ISO 7 cleanrooms, hermeticity testing, laser seam welding, and microfabrication are co-located inside the hospital.
  • University of MelbournecoreStrategic or Co-development PartnerDr. Robert Crombie, Head of Enterprise Partnerships & Innovation Initiatives at the University of Melbourne, represents the University on the Neo-Bionica Board, bringing extensive experience in biotech strategy and business development. The partnership provides access to academic research, talent, and innovation pipelines from one of Australia's leading biomedical research institutions.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Neo-Bionica competitors and assessment

Company assessment

Direct peers

  • Cirtec Medical: US-based CDMO specializing in active implantable medical devices, neuromodulation, and minimally invasive surgical devices. Closest direct peer to Neo-Bionica in terms of active implantable electronics manufacturing and Class III device engineering depth.
  • Minnetronix Medical: Medical device CDMO with strong active implantable and neuro/neuromodulation capabilities, providing design, manufacturing, and regulatory services. Direct peer in the neurotech-focused contract development and manufacturing niche.
  • StarFish Medical: Canadian medical device design, development, and contract manufacturing organization serving startups through commercial-stage medtech. Direct peer in early-stage medical device CDMO services, including neurotech and Class III programs.

Regional players

  • Planet Innovation: Australian medical device and life sciences product development and manufacturing company, including Class III implantable work. Direct regional peer with overlapping capabilities in neurotech-adjacent implantable engineering.

Broad incumbents

  • Integer Holdings: Large US-listed medical device outsource manufacturer with significant active implantable and neuromodulation manufacturing capacity. Broad incumbent competing in the same end-markets from a much larger scale.
  • Resonetics: Global medical device contract manufacturer with capabilities in nitinol, laser processing, and complex implantable components. Broad incumbent serving overlapping neurotech and implantable customer bases.
  • Nordson Medical: Medical device component and contract manufacturing business of Nordson, including precision engineered components for neuro and other implantables. Broad incumbent with overlapping manufacturing capabilities.

Emerging players

  • Cambridge Consultants: Deep-tech product development and engineering consultancy with active neurotechnology and brain-computer interface practices. Emerging player providing adjacent design and development services to the same neurotech startup segment.
  • TTP plc: UK-based technology and product development consultancy with deep neurotech, drug delivery, and implantable device capabilities. Emerging player offering competing design and engineering services to neurotech innovators.
  • Helbling Group: Swiss engineering services and product development firm with a dedicated medical devices and neurotechnology practice. Emerging player providing comparable design and development services to early-stage neurotech clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Neo-Bionica social profiles

Digital presence

Neo-Bionica compliance and trust

Trust signal

Compliance3 records

Neo-Bionica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neo-Bionica leadership team

Management profile

Number of profiles

Profiles14 records

Neo-Bionica funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neo-Bionica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neo-Bionica

What does Neo-Bionica do?

Neo-Bionica is a contract development and manufacturing organization (CDMO) that provides end-to-end design, engineering, prototyping, and clinical-grade manufacturing services for active implantable and wearable neurotechnology medical devices, taking clients from early-stage concept through First-in-Human clinical trials. Its service platform is organized into five interlocking modules: Design and Develop, Build and Assemble, Test and Validate, Commercialise, and Prototype and Manufacture, all delivered from an ISO 13485-certified, hospital-integrated facility at St. Vincent's Hospital Melbourne.

Is Neo-Bionica a public or private company?

Neo-Bionica is a private company. It is classified as venture growth investor backed and is currently operating.

When was Neo-Bionica founded?

Neo-Bionica was founded in 2021. It employs 11 to 50 people.

Where is Neo-Bionica based?

Neo-Bionica is headquartered in Fitzroy, Australia, in the Oceania region.

How does Neo-Bionica make money?

Three revenue lines are on record. CDMO Design & Engineering Services are the primary driver. The others are pre-Clinical and Clinical Trial Build Services and regulatory and Commercialisation Support Services.

Who are Neo-Bionica's main competitors?

Direct peers on record are Cirtec Medical, Minnetronix Medical and StarFish Medical. Planet Innovation is listed as a regional player. Broad incumbents are Integer Holdings, Resonetics and Nordson Medical. Emerging players are Cambridge Consultants, TTP plc and Helbling Group.

Does Neo-Bionica have an API?

No public API is recorded for Neo-Bionica.

What industry is Neo-Bionica in?

Neo-Bionica's product category is Medical Device Contract Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals